九洲药业股价涨5.01%，国联基金旗下1只基金重仓，持有4.02万股浮盈赚取3.94万元

Group 1 - The core point of the news is that Jiuzhou Pharmaceutical experienced a stock price increase of 5.01%, reaching 20.53 CNY per share, with a trading volume of 673 million CNY and a turnover rate of 3.79%, resulting in a total market capitalization of 18.26 billion CNY [1] - Jiuzhou Pharmaceutical, established on July 13, 1998, and listed on October 10, 2014, is primarily engaged in the research, production, and sales of chemical raw materials and pharmaceutical intermediates. The revenue composition includes 79.81% from new drug custom development and manufacturing services (CDMO), 18.22% from specialty raw materials and intermediates, and 1.96% from other sources [1] Group 2 - From the perspective of major fund holdings, Guolian Fund has one fund heavily invested in Jiuzhou Pharmaceutical. The Guolian Smart Selection Pioneer Stock A (020748) held 40,200 shares in the second quarter, accounting for 0.39% of the fund's net value, making it the third-largest holding. The estimated floating profit today is approximately 39,400 CNY [2] - The Guolian Smart Selection Pioneer Stock A (020748) has a year-to-date return of 33.41%, ranking 1275 out of 4220 in its category, and a one-year return of 42.87%, ranking 892 out of 3857. Since its inception, the fund has achieved a return of 64.42% [2]